10,000 eczema patients enrolled in massive real-world drug safety study
NCT ID NCT04504955
First seen Feb 15, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study follows 10,000 adults with atopic dermatitis (eczema) to see how well approved treatments work and how safe they are in everyday medical practice. Researchers will also track the disease's natural history, related health problems, and current treatment patterns. Participants continue their usual care with their dermatologist.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.